BOLT - CIK 0001641281
Bolt Biotherapeutics, Inc. (BOLT) reported revenue of $7.70M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $7.70M | +0.1% |
| FY 2024 | $7.69M | -2.4% |
| FY 2023 | $7.88M | +37.5% |
| FY 2022 | $5.73M | +354.7% |
| FY 2021 | $1.26M | +445.5% |
| FY 2020 | $231.00K | - |
Bolt Biotherapeutics, Inc. (BOLT) reported revenue of $7.70M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Bolt Biotherapeutics, Inc.'s revenue grew from $231.00K to $7.70M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.